日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

早期奥司他韦治疗对甲型流感住院成人患者的益处:一项观察性研究

Lewis, Nathaniel M; Harker, Elizabeth J; Grant, Lauren B; Zhu, Yuwei; Grijalva, Carlos G; Chappell, James D; Rhoads, Jillian P; Baughman, Adrienne; Casey, Jonathan D; Blair, Paul W; Jones, Ian D; Johnson, Cassandra A; Lauring, Adam S; Gaglani, Manju; Ghamande, Shekhar; Columbus, Cristie; Steingrub, Jay S; Shapiro, Nathan I; Duggal, Abhijit; Busse, Laurence W; Felzer, Jamie; Prekker, Matthew E; Peltan, Ithan D; Brown, Samuel M; Hager, David N; Gong, Michelle N; Mohamed, Amira; Exline, Matthew C; Khan, Akram; Hough, Catherine L; Wilson, Jennifer G; Mosier, Jarrod; Qadir, Nida; Chang, Steven Y; Ginde, Adit A; Martinez, Amanda; Mohr, Nicholas M; Mallow, Christopher; Harris, Estelle S; Johnson, Nicholas J; Srinivasan, Vasisht; Gibbs, Kevin W; Kwon, Jennie H; Vaughn, Ivana A; Ramesh, Mayur; Safdar, Basmah; Goyal, Anirudh; DeLamielleure, Lauren E; DeCuir, Jennifer; Surie, Diya; Dawood, Fatimah S; Tenforde, Mark W; Uyeki, Timothy M; Garg, Shikha; Ellington, Sascha; Self, Wesley H

Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024

2023-2024 年更新版(单价 XBB.1.5)COVID-19 疫苗对 SARS-CoV-2 Omicron XBB 和 BA.2.86/JN.1 谱系住院治疗的有效性及临床严重程度比较 - IVY 网络,26 家医院,2023 年 10 月 18 日至 2024 年 3 月 9 日

Ma, Kevin C; Surie, Diya; Lauring, Adam S; Martin, Emily T; Leis, Aleda M; Papalambros, Leigh; Gaglani, Manjusha; Columbus, Christie; Gottlieb, Robert L; Ghamande, Shekhar; Peltan, Ithan D; Brown, Samuel M; Ginde, Adit A; Mohr, Nicholas M; Gibbs, Kevin W; Hager, David N; Saeed, Safa; Prekker, Matthew E; Gong, Michelle Ng; Mohamed, Amira; Johnson, Nicholas J; Srinivasan, Vasisht; Steingrub, Jay S; Khan, Akram; Hough, Catherine L; Duggal, Abhijit; Wilson, Jennifer G; Qadir, Nida; Chang, Steven Y; Mallow, Christopher; Kwon, Jennie H; Parikh, Bijal; Exline, Matthew C; Vaughn, Ivana A; Ramesh, Mayur; Safdar, Basmah; Mosier, Jarrod; Harris, Estelle S; Shapiro, Nathan I; Felzer, Jamie; Zhu, Yuwei; Grijalva, Carlos G; Halasa, Natasha; Chappell, James D; Womack, Kelsey N; Rhoads, Jillian P; Baughman, Adrienne; Swan, Sydney A; Johnson, Cassandra A; Rice, Todd W; Casey, Jonathan D; Blair, Paul W; Han, Jin H; Ellington, Sascha; Lewis, Nathaniel M; Thornburg, Natalie; Paden, Clinton R; Atherton, Lydia J; Self, Wesley H; Dawood, Fatimah S; DeCuir, Jennifer

Sarcoidosis extent relates to molecular variability

结节病的程度与分子变异有关

C S Monast, K Li, M A Judson, R P Baughman, E Wadman, R Watt, P E Silkoff, E S Barnathan, C Brodmerkel

Clinical characteristics of sarcoidosis patients in the United States versus China

美国与中国结节病患者的临床特征比较

Ying, Zhou; Elyse, E Lower; Yinping, Feng; Shanshan, Du; Huiping, Li; Robert, P Baughman

Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax

肠外给药的基于结构的合理修饰重组葡萄球菌肠毒素B蛋白疫苗STEBVax的安全性和免疫原性研究

Chen, Wilbur H; Pasetti, Marcela F; Adhikari, Rajan P; Baughman, Holly; Douglas, Robin; El-Khorazaty, Jill; Greenberg, Nancy; Holtsberg, Frederick W; Liao, Grant C; Reymann, Mardi K; Wang, Xiaolin; Warfield, Kelly L; Aman, M Javad

Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response

CXCL8/IL-8 与结核分枝杆菌的结合调节先天免疫反应

Agnieszka Krupa, Marek Fol, Bozena R Dziadek, Ewa Kepka, Dominika Wojciechowska, Anna Brzostek, Agnieszka Torzewska, Jaroslaw Dziadek, Robert P Baughman, David Griffith, Anna K Kurdowska